Factors associated with uncontrolled hypertension in an affluent, elderly population

Annals of Pharmacotherapy

Volumn 37, Issue 4, 2003, Pages 485-489

  Inciardi, John F ^a   McMahon, Kay ^b   Sauer, Barbara L ^a   Morand, Brenda R ^c   Mallet, Louise ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BUCK INSTITUTE FOR RESEARCH ON AGING   (United States)

^c San Francisco ^*

Author keywords

Diuretics; Elderly; Hypertension

Indexed keywords

DIURETIC AGENT;

ADULT; AGED; AGING; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; DAILY LIFE ACTIVITY; DISEASE ASSOCIATION; ELDERLY CARE; FEMALE; HUMAN; HYPERTENSION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; POPULATION RESEARCH; PRIORITY JOURNAL; RISK FACTOR; SOCIOECONOMICS;

EID: 0037381813     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1C370     Document Type: Article

References (13)

1. National High Blood Pressure Education Program Education Program Working Group Report on Hypertension in the Elderly. National High Blood Pressure Education Program Working Group. Hypertension 1994; 23:275-85.
2. Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in the patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. Lancet 1998;351:1755-62.
3. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991;265:3255-64.
4. Dahlof B, Lindholm LH, Hansson L, Schersten B, Ekbom T, Wester PO. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet 1991;338:1281-5.
5. Fagard RH, Staessen JA, Thijs L, Gasowski J, Bulpitt CJ, Clement D, et al. Response to antihypertensive therapy in older patients with sustained and nonsustained systolic hypertension. Circulation 2000;102:1139-44.
6. Reed D, Satariano WA, Gildengorin G, McMahon K, Fleshman R, Schneider E. Health and functioning among the elderly of Marin County, California: a glimpse of the future. J Gerontol A Biol Sci Med Sci 1995; 50:M61-9.
7. McMahon K, McEnhill M, Youngquist R. Utilizing volunteer research assistants in epidemiologic studies. J Aging Soc Policy 1996;8: 39-47.
8. Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. The sixth report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure. Arch Intern Med 1997;157:2413-45.
9. Whelton PK, He J, Appel LJ, Cutler JA, Havas S, Kotchen TA, et al. Primary prevention of hypertension: clinical and public health advisory from the National High Blood Pressure Education Program. JAMA 2002;288:1882-8.
10. Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, et al. Prevalence of hypertension in the US adult population - results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995;25(N3):305-13.
11. Fierro-Carrion GA, Ram VS. Nonsteroidal anti-inflammatory drugs (NSAIDs) and blood pressure. Am J Cardiol 1997;80:775-6.
12. Morgan TO, Anderson A, Bertram D. Effect of indomethacin on blood pressure in elderly people with essential hypertension well controlled on amlodipine or enalapril. Am J Hypertens 2000;13:1161-7.
13. Collins R, Peto R, MacMahon S, Herbert P, Fiebach N, Eberlein KA, et al. Blood pressure, stroke and coronary heart disease. Part 2, short-term reductions in blood pressure: overview of randomized drug trials in their epidemiological context. Lancet 1990;335:827-38.